已收盘 02-06 16:00:00 美东时间
+4.030
+2.54%
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
Goldman Sachs analyst James Yaro maintains PJT Partners (NYSE:PJT) with a Neutral and lowers the price target from $197 to $174.
02-05 00:52
华盛资讯2月3日讯,PJT Partners, Inc. Class A公布2025财年Q4业绩,公司Q4营收5.35亿美元,同比增长12.1%,归母净利润0.53亿美元,同比增长4.0%。
02-03 22:05
PJT Partners (NYSE:PJT) just disclosed its Q4 earnings on Tuesday, February 3, ...
02-03 20:14
PJT Partners (NYSE:PJT) reported its Q4 earnings results on Tuesday, February 3...
02-03 19:54
Companies Reporting Before The Bell • Atkore (NYSE:ATKR) is expected to report ...
02-03 19:11
PJT Partners (NYSE:PJT) is preparing to release its quarterly earnings on Tuesd...
02-03 02:03
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
Keefe, Bruyette & Woods analyst Aidan Hall maintains PJT Partners (NYSE:PJT) with a Market Perform and raises the price target from $186 to $188.
01-08 23:58
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54